Schedule 13G ownership disclosure

Corvus Pharmaceuticals Inc

Security class unavailable · CUSIP: 221015100

Event date: 2016-03-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,067,826
Percent of class
5.2300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-110585
Form type
SC 13G
Filer
Corvus Pharmaceuticals, Inc.
CIK
CIK 1626971
Filed
Apr 08, 2016
Reporting period
Mar 22, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub